SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on December 6, 2019, reporting an event that occurred on December 4, 2019. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange (NYSE) under the symbol RMED.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
On December 4, 2019, the Company received a formal notice from the NYSE stating it was not in compliance with one of the continued listing standards applicable to the Company. The specific standard violated is not detailed in the text of this filing.
Outlook, Risks, and Management Commentary
The Company issued a press release on December 6, 2019, to publicly announce the receipt of the noncompliance notice. The primary risk identified is the potential delisting or failure to satisfy continued listing rules. No forward-looking guidance or management commentary regarding financial outlook is included in this document.
Investor Verification Checklist
- Verify the specific NYSE listing standard with which the company is currently non-compliant.
- Review the attached press release (Exhibit 99.1) for details on the company's remediation plan.
- Monitor subsequent filings for updates on the company's compliance status or potential delisting proceedings.
- Confirm the company's current stock price and trading volume following the announcement.